Status:
COMPLETED
Stanford ICU Delirium PIPRA Study
Lead Sponsor:
Stanford University
Conditions:
Delirium
Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the accuracy of the Pre-Interventional Preventive Risk Assessment (PIPRA) tool in predicting clinical cases of Intensive Care Units (ICU)-delirium, in a popul...
Detailed Description
Study investigators would like to determine the real-life accuracy of a new tool developed for the prediction of delirium: Pre-Interventional Preventive Risk Assessment (PIPRA) Tool. The importance of...
Eligibility Criteria
Inclusion
- Age is 18 years or older
- Clinical suspicion of delirium or subject at risk for delirium 3. Admitted to the Intensive Care Unit (ICU)
- 4\. Expected ICU stay is greater than one (1) day 5. Subject must be fluent in English
Exclusion
- Age is younger than 18 years
- Subjects with a primary neurological or neurosurgical condition such as stroke, epilepsy, brain tumor, or witnessed seizures, Parkinson's disease, traumatic brain injury, craniectomy, known severe dementia, or Central Nervous System (CNS) infection
- Active CNS substance abuse, intoxication, or withdrawal
- Unarousable or unresponsive subjects with Richmond Agitation Sedation Scale (RASS) \<-3
- Subject is blind, deaf, or unable to speak or understand English
Key Trial Info
Start Date :
April 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 27 2024
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT06519890
Start Date
April 30 2024
End Date
July 27 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Medical Center
Palo Alto, California, United States, 94304